The question then arises whether NF-κB can be effectively targeted by WA to inhibit obesity induced inflammation and thus its related cardiovascular diseases since this would necessitate long term treatment and the factor is required for basic immune responses. This evidence concerns the gene NFKB1 and cardiovascular disorder.